CareDx WKN: A118WG ISIN: US14167L1035 Kürzel: 1K9
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
Anzeige
Alles ab 0 Euro pro Order. Dauerhaft.


Summer.76,
Dienstag 16:24
https://www.globenewswire.com/news-release/2022/05/24/2449070/31386/en/CareDx-Receives-CE-Mark-for-AlloSeq-HCT-for-Use-in-Hematopoietic-Cell-Transplantation.html

Summer.76,
17. Mai 16:58
https://www.globenewswire.com/news-release/2022/05/17/2444754/31386/en/In-CareDx-Initiated-IP-Litigation-Against-Natera-Natera-Now-Drops-1-of-2-Patents-Originally-Asserted-Against-CareDx.html

Summer.76,
6. Mai 5:55
CareDx Reports First Quarter 2022 Results
https://www.globenewswire.com/news-release/2022/05/05/2437284/31386/en/CareDx-Reports-First-Quarter-2022-Results.html

Summer.76,
5. Mai 15:19
https://www.globenewswire.com/news-release/2022/05/05/2436571/31386/en/CareDx-Validates-Clinical-Performance-of-AlloMap-Kidney-to-Comprehensively-Assess-Transplant-Rejection.html

Summer.76,
14. Apr 19:42
https://www.globenewswire.com/news-release/2022/04/14/2422640/31386/en/CareDx-Reports-Over-200-000-Heart-Transplant-Patient-Results-Served.html
CareDx Reports Over 200,000 Heart Transplant Patient Results Served
CareDx Testing Services Have Been Used in Over 30,000 Heart Transplant Patients and Over 90 Percent of Centers in the United States

Summer.76,
11. Apr 16:12
https://www.globenewswire.com/news-release/2022/04/11/2419896/31386/en/CareDx-the-Leading-Sponsor-of-UNOS-Transplant-Management-Forum-Demonstrates-the-Value-of-Digital-Solutions-to-Improve-Pre-Transplant-Patient-Referral-and-Waitlisting-Workflow.html

Summer.76,
30. Mär 17:52
https://www.globenewswire.com/news-release/2022/03/30/2412689/31386/en/CareDx-Partners-with-the-European-Society-for-Organ-Transplantation-to-Provide-Clinical-Evidence-Supporting-the-Use-of-AlloSeq-cfDNA-with-European-Transplant-Healthcare-Professiona.html

Summer.76,
24. Mär 20:07
https://www.globenewswire.com/news-release/2022/03/24/2409242/0/en/CareDx-s-AlloCare-App-Now-Integrated-with-TxAccess-to-Help-Pre-Transplant-Patients-Navigate-the-Waitlist-Process.html

Summer.76,
15. Mär 9:25
CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; ...
https://www.bakersfield.com/ap/news/caredx-wins-44-9m-in-damages-in-false-advertising-trial-against-natera-natera-intentionally/article_8849930e-0d01-591f-b643-3ba8c4035548.html

Summer.76,
3. Mär 15:13
CareDx Announces Cibiltech Initiates CIBIL Study Using iBox Artificial Intelligence to Monitor Kidney Transplant Patients
https://www.globenewswire.com/news-release/2022/03/03/2396118/31386/en/CareDx-Announces-Cibiltech-Initiates-CIBIL-Study-Using-iBox-Artificial-Intelligence-to-Monitor-Kidney-Transplant-Patients.html
Results from CareDx’s OKRA Study and Cibiltech’s CIBIL Study will Demonstrate Clinical Utility of iBox for Transplant Patient Management
|
Kommentare | ||
---|---|---|---|
1 | CAREDX INC. DL-,001 Hauptdiskussion |
Kursdetails
Geld (bid) | 26,12 (2.500) |
---|---|
Brief (ask/offer) | 26,17 (8.000) |
Spread | 0,19 |
Geh. Stück | 634 Tsd. |
Eröffnung | 24,31 |
Vortag | 24,31 |
Tageshoch | 26,21 |
Tagestief | 24,09 |
52W Hoch | 96,75 |
52W Tief | 21,35 |
Tagesvolumen
in EUR gehandelt | 6 Stk |
---|---|
in USD gehandelt | 634 Tsd. Stk |
in GBP gehandelt | 0 Stk |
Gesamt | 634 Tsd. Stk |
Anzeige

Der Broker von Deutschlands größter Finanzcommunity
Meldungen
- Blender Bites Inc.: Blender Bites meldet Nachbestellung der preisgekrönten innovativen Smoothie-Produkte durch die Region Ostkanada der weltweit größten Club-Store-Kette
- Dow gelingt größtes Wochenplus seit 2020
- First Majestic Silver Corp.: First Majestic gibt Abstimmungsergebnisse der Jahreshaupt- und Sonderversammlung bekannt
- Markterholung beschert Dow größtes Wochenplus seit 2020
- Die wichtigsten Finanztermine am 30.05.2022
Geld/Brief Kurse
Börse | Geld | Brief | Zeit | Volumen | Kurs |
---|---|---|---|---|---|
Frankfurt | 24,28 | 24,49 | 1653631725 27. May | 21,93 EUR | |
Berlin | 24,18 | 24,59 | 1653681162 27. May | 24,27 EUR | |
Düsseldorf | 24,26 | 24,48 | 1653672686 27. May | 24,10 EUR | |
München | 24,18 | 24,54 | 1653631378 27. May | 22,23 EUR | |
Stuttgart | 24,27 | 24,44 | 1653631256 27. May | 22,01 EUR | |
Nasdaq | 26,12 | 26,17 | 1653696000 28. May | 634.266 Stk | 26,17 USD |
AMEX | 1653696000 28. May | 100 Stk | 26,12 USD | ||
Tradegate | 24,15 | 24,58 | 1653683224 27. May | 6 Stk | 24,36 EUR |
Lang & Schwarz | 24,12 | 24,61 | 1653685089 27. May | 24,36 EUR | |
London | 1653574571 26. May | 24,48 GBP | |||
Gettex | 24,18 | 24,55 | 1653680580 27. May | 24,26 EUR | |
Baader Bank | 24,18 | 24,55 | 1653681599 27. May | 24,36 EUR | |
TTMzero RT | 1653636356 27. May | 22,34 EUR | ges. 634.372 Stk |
Realtime / Verzögert
Börsennotierung
Marktkapitalisierung in EUR |
---|
2,0 Mrd. |
Anzahl der Aktien |
53,2 Mio. |
Grundlegende Daten zur CAREDX INC. DL-,001 Aktie
Finanzdaten | 2018 | 2019 | 2020 | 2021 | 2022e | 2023e | 2024e |
---|---|---|---|---|---|---|---|
KUV | - | - | - | - | - | - | - |
Ergebnis je Aktie (bereinigt) | - | - | - | - | - | - | - |
Cashflow | - | - | - | - | - | - | - |
Eigenkapitalquote | - | - | - | - | - | - | - |
Verschuldungsgrad | - | - | - | - | - | - | - |
Eigenkapitalrendite | - | - | - | - | - | - | - |
Gesamtkapitalrendite | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - |
EBIT | - | - | - | - | - | - | - |
Fundamentaldaten | 2018 | 2019 | 2020 | 2021 | 2022e | 2023e | 2024e |
KCV | - | - | - | - | - | - | - |
Dividendenrendite | - | - | - | - | - | - | - |
Kurs-Gewinn-Verhältnis (KGV) | - | - | - | - | - | - | - |
Dividende je Aktie | - | - | - | - | - | - | - |
Bilanzdaten | 2018 | 2019 | 2020 | 2021 | 2022e | 2023e | 2024e |
Netto-Provisionsüberschuss | - | - | - | - | - | - | - |
Umsatzerlöse | - | - | - | - | - | - | - |
Ergebnis vor Steuern | - | - | - | - | - | - | - |
Steuern | - | - | - | - | - | - | - |
Ausschüttungssumme | - | - | - | - | - | - | - |
Nettoverzinsung | - | - | - | - | - | - | - |
Zinsertrag | - | - | - | - | - | - | - |
Gesamtertrag | - | - | - | - | - | - | - |